The global Bedsore Medicine market size is predicted to grow from US$ 1591 million in 2025 to US$ 2155 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.

Bedsore drugs refer to a class of drugs and care products used to prevent, treat and manage skin and subcutaneous tissue damage caused by long-term pressure. These drugs and products are designed to reduce pain, control infection, promote wound healing, and minimize complications. Focus on statistics of patients in the most commonly used bedsore dressing and antibiotics.

United States market for Bedsore Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bedsore Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bedsore Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bedsore Medicine players cover Nipro, Chongqing Kerui Pharmaceutical, Smith & Nephew, Convatec, B Braun Melsungen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Bedsore Medicine Industry Forecast” looks at past sales and reviews total world Bedsore Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Bedsore Medicine sales for 2025 through 2031. With Bedsore Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bedsore Medicine industry.

This Insight Report provides a comprehensive analysis of the global Bedsore Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bedsore Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bedsore Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bedsore Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bedsore Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Bedsore Medicine market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Dressing
    Antibiotic Ointment

Segmentation by Application:

    Hospital
    Clinic
    Pharmacy
    Online

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Nipro
    Chongqing Kerui Pharmaceutical
    Smith & Nephew
    Convatec
    B Braun Melsungen
    Kaken Pharmaceutical
    Tayca Pharmaceutical
    Meiji Holdings
    Ono Pharmaceutical
    Sun Pharma
    KYORIN Rimedio
    Taiho Pharmaceutical
    Teikoku Pharmacare Coporation
    J-dolph Pharmaceutical
    RegeneRx
    FunPep
    Aurealis Therapeutics
    Paul Hartmann
    Coloplast
    Energenesis Biomedical
    Shanghai Tenry Pharm
    Hubei Mayinglong Pharmaceutical
    Glenmark Pharms
    Glaxosmithkline
    Sino-American Tianjin SmithKline
    Hubei Renfu Chengtian Pharmaceutical
    Hangzhou Zhuyangxin Pharmaceutical
    GSK
    Perrigo
    Bausch Health
    Taro Pharmaceutical
    Teva
    Jiangxi Xinglin Baima Pharmaceutical
    Suzhou Hongsen Pharmaceutical
    Henan Quanyu Pharmaceutical
    Shenyang Hongqi Pharmaceutical